Introduction
The NUT midline carcinoma treatment market is gaining increasing attention within the oncology sector due to the rising focus on rare and aggressive cancers. NUT midline carcinoma is a rare and highly aggressive form of cancer characterized by chromosomal rearrangements involving the NUT gene, often leading to rapid disease progression and poor prognosis.
The rarity of the...